Skip to main
BLFS

BioLife Solutions (BLFS) Stock Forecast & Price Target

BioLife Solutions (BLFS) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BioLife Solutions Inc. reported a significant year-over-year revenue increase, with Cell Processing revenue reaching $25.3 million, reflecting a growth of 33%, and total revenue for 3Q25 at $28.1 million, which is a 31% year-over-year growth and exceeding projections. The company also achieved a net income of $0.6 million, or $0.01 per share, contrasting sharply with prior estimates of a net loss, which indicates improved profitability. Furthermore, BioLife Solutions is positioned for continued growth with expectations of gross margins in the low-60% range and a reduction in net losses, supported by a strong cash position and the anticipated benefits from their Center for biopreservation and cell processing innovations.

Bears say

The financial outlook for BioLife Solutions Inc. is hindered by several significant risks, including the potential for lower-than-anticipated growth of its products and services and difficulties in acquiring new customers. Additionally, revenue guidance for FY2025 was adjusted downward by approximately $8 million, indicating expectations for only 27-29% year-over-year growth, predominantly driven by its Cell Processing platform. Furthermore, the company faces challenges such as fluctuations in foreign exchange rates and potential dilution, which could negatively impact its financial stability and long-term growth prospects.

BioLife Solutions (BLFS) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BioLife Solutions and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BioLife Solutions (BLFS) Forecast

Analysts have given BioLife Solutions (BLFS) a Strong Buy based on their latest research and market trends.

According to 1 analysts, BioLife Solutions (BLFS) has a Strong Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $32, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $32, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BioLife Solutions (BLFS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.